BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33525499)

  • 1. New Highlights of Resveratrol: A Review of Properties against Ocular Diseases.
    Delmas D; Cornebise C; Courtaut F; Xiao J; Aires V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases.
    Lançon A; Frazzi R; Latruffe N
    Molecules; 2016 Mar; 21(3):304. PubMed ID: 26950104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and reactive oxygen species: a review of their role in ocular disease.
    Ung L; Pattamatta U; Carnt N; Wilkinson-Berka JL; Liew G; White AJR
    Clin Sci (Lond); 2017 Dec; 131(24):2865-2883. PubMed ID: 29203723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and the eye: activity and molecular mechanisms.
    Bola C; Bartlett H; Eperjesi F
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):699-713. PubMed ID: 24652235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action.
    Ahmad I; Hoda M
    Life Sci; 2020 Mar; 245():117350. PubMed ID: 31982401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol protects photoreceptors by blocking caspase- and PARP-dependent cell death pathways.
    Liu SY; Song JY; Fan B; Wang Y; Pan YR; Che L; Sun YJ; Li GY
    Free Radic Biol Med; 2018 Dec; 129():569-581. PubMed ID: 30342188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases.
    Zhou DD; Luo M; Huang SY; Saimaiti A; Shang A; Gan RY; Li HB
    Oxid Med Cell Longev; 2021; 2021():9932218. PubMed ID: 34336123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Resveratrol in Eye Diseases-A Review of the Literature.
    Bryl A; Falkowski M; Zorena K; Mrugacz M
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis of molecular mechanism of resveratrol for treating pulmonary hypertension based on network pharmacology technology.
    Chen Y; Yuan T; Chen D; Liu S; Guo J; Fang L; Du G
    Eur J Pharmacol; 2020 Dec; 888():173466. PubMed ID: 32798507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of resveratrol in regulation of cellular defense systems against oxidative stress.
    Truong VL; Jun M; Jeong WS
    Biofactors; 2018 Jan; 44(1):36-49. PubMed ID: 29193412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension.
    Cao K; Ishida T; Fang Y; Shinohara K; Li X; Nagaoka N; Ohno-Matsui K; Yoshida T
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):13. PubMed ID: 32176263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance.
    Goutham G; Manikandan R; Beulaja M; Thiagarajan R; Arulvasu C; Arumugam M; Setzer WN; Daglia M; Nabavi SF; Nabavi SM
    Biomed Pharmacother; 2017 Feb; 86():232-241. PubMed ID: 28006748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of SIRT1 in ocular aging.
    Mimura T; Kaji Y; Noma H; Funatsu H; Okamoto S
    Exp Eye Res; 2013 Nov; 116():17-26. PubMed ID: 23892278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Resveratrol in Transmitochondrial AMD RPE Cells.
    Nashine S; Nesburn AB; Kuppermann BD; Kenney MC
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31935891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol improved the developmental potential of oocytes after vitrification by modifying the epigenetics.
    Chen H; Zhang L; Wang Z; Chang H; Xie X; Fu L; Zhang Y; Quan F
    Mol Reprod Dev; 2019 Jul; 86(7):862-870. PubMed ID: 31066155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets.
    Farghali H; Kutinová Canová N; Lekić N
    Physiol Res; 2013; 62(1):1-13. PubMed ID: 23173686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications.
    Karimi M; Abiri B; Guest PC; Vafa M
    Methods Mol Biol; 2022; 2343():19-35. PubMed ID: 34473313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: Epigenetic mechanisms in ocular disease.
    He S; Li X; Chan N; Hinton DR
    Mol Vis; 2013; 19():665-74. PubMed ID: 23559860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALSUntangled no. 49: resveratrol.
    ALSUNTANGLED GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):619-624. PubMed ID: 30945567
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound.
    Samuel VP; Gupta G; Dahiya R; Jain DA; Mishra A; Dua K
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):529-537. PubMed ID: 32422008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.